InsidersTradesSigma
Track the Aurobindo Pharma Limited stock price and the full management transaction log of the company, a listed equity based in India. Shares trade on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Aurobindo Pharma Limited has logged 168 reports. Market capitalisation: €907bn. The latest transaction was disclosed on 30 March 2024 (Pledge). Among the most active insiders: RPR SONS ADVISORS PVT.LTD., P.SUNEELA RANI (Jointly holding). Every trade is openly available.
168
Insider Decl.
n/a
Thresholds
€1m
4 ops.
Buy Volume
€11m
65 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Aurobindo Pharma Limited Buy (bullish), based on 29 analysts. Average price target: ₹1,570.83.
10Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 9,670 of 29,064 companies
59.9
score / 100
Value51
Quality69
FCF yld2.7%
Earn yld3.9%
EV/EBITDA13.6x
ROE9.9%
Gross mgn60%
Net mgn10%
Debt/EBITDA1.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 30 March 2024
Declarations168 total
11,635,862 shares@ ₹1,088.7511.0% of flowEquity SharesSEBI:5e6c283adca6bfea5b27836809cf3ca381b6e7ce
16,700,000 shares@ ₹1,053.0515.2% of flowEquity SharesSEBI:67aa7b1e0f97fd1e83b4e56721569ec3a273a71f
1,000 shares@ ₹1,022.0044.2% of flowEquity SharesSEBI:c76bab9f89aadb29f9c0debc58ebc930712be0c7
2,000 shares@ ₹1,047.3875100.0% of flowEquity SharesSEBI:0a27db88c87689bbf58ab51b2460a877ac39a175
10,050,000 shares@ ₹1,043.809.2% of flowEquity SharesSEBI:ae693db06237826e067fc058b2c1697f6875ea91
2,300,000 shares@ ₹1,043.802.1% of flowEquity SharesSEBI:77b5a7d9adc270e847fb494111cc85be9a56511c
35,000 shares@ ₹1,017.11100.0% of flowEquity SharesSEBI:84d4ae9eb9a49dffb4b1dedecc6b363b7ad12f93
3,880 shares@ ₹1,011.0928100.0% of flowEquity SharesSEBI:cdc43a8ac1111e691637677a421b0cc98cee8957
13,400,000 shares@ ₹996.1011.8% of flowEquity SharesSEBI:6fdea43e87a1ce84c066cc2fd65d923d1bc14671
2,000 shares@ ₹1,027.00100.0% of flowEquity SharesSEBI:f32b92c21022933d84e32558b34c814148790139
400,000 shares@ ₹1,124.800.4% of flowEquity SharesSEBI:8885e7d92541ff50c64b99164f9c9f5914a3cdb6
250,000 shares@ ₹1,118.850.2% of flowEquity SharesSEBI:d39909e7143ecf0c9f2cbcba68b8f240c2bbd3ac
1,000 shares@ ₹1,082.60100.0% of flowEquity SharesSEBI:ac0a8f8a76db047676dd5b8ca1f2b0b5644c24fb
1,000 shares@ ₹1,079.00100.0% of flowEquity SharesSEBI:c951329bc328c199a1218856efd3887f796545de
15,000 shares@ ₹1,071.6160.7% of flowEquity SharesSEBI:f86158fa16c626484a9ef5361db80291ce6e7ad4
9,000 shares@ ₹1,080.0162100.0% of flowEquity SharesSEBI:f0ce706da77de3c47b157ce7a04e0f091a23ac9c
4,000 shares@ ₹1,077.50100.0% of flowEquity SharesSEBI:16f1920e021956596fbbd3046d12ba17b63250bc
2,500 shares@ ₹1,085.0032.0% of flowEquity SharesSEBI:12ffb27351ca6b8706ea3f7014d84a0a6b2d31ca
1,500 shares@ ₹1,065.6667100.0% of flowEquity SharesSEBI:97a2e86bb3aacfde85f1f0c7ad30a6c5eebe1b74
3,500 shares@ ₹1,067.9863100.0% of flowEquity SharesSEBI:4c69fd9b6a247323cfddca168a15740fdb60247f
1,500 shares@ ₹1,044.00100.0% of flowEquity SharesSEBI:e8b13707769a951413941583412f3610ac113a92
1,000 shares@ ₹1,014.00100.0% of flowEquity SharesSEBI:6d45dc43a88b76419c27dea6e1055aed8032cfa4
3,000 shares@ ₹1,040.5011.7% of flowEquity SharesSEBI:85fd80c8469e974740bf05287bc279b5a48366cf
1,350 shares@ ₹1,022.40100.0% of flowEquity SharesSEBI:341d575722aca4b11c47ea3f5cca633fa64cc343
25 of 168 declarations
关于 Aurobindo Pharma Limited
Aurobindo Pharma Limited 是一家印度制药公司，专门生产仿制药和医药产品。该公司在孟买证券交易所上市，股票代码为 XBOM。